Healthcare provider profile · identity verified

Javier Gascot

General Practice · BAYAMON, PR · NPI 1386694305

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	633	142
Losartan Potassium	Losartan Potassium	493	97
Metformin Hcl	Metformin Hcl	431	86
Levothyroxine Sodium	Levothyroxine Sodium	429	75
Gabapentin	Gabapentin	426	77
Diclofenac Potassium	Diclofenac Potassium	388	122
Omeprazole	Omeprazole	346	85
Amlodipine Besylate	Amlodipine Besylate	325	67
Montelukast Sodium	Montelukast Sodium	297	72
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	292	60
Lisinopril	Lisinopril	282	51
Synthroid	Levothyroxine Sodium	279	54
Hydrochlorothiazide	Hydrochlorothiazide	275	54
Metoprolol Succinate	Metoprolol Succinate	242	55
Alendronate Sodium	Alendronate Sodium	229	44
Famotidine	Famotidine	221	43
Pantoprazole Sodium	Pantoprazole Sodium	214	50
Memantine Hcl	Memantine Hcl	213	29
Clonazepam	Clonazepam	200	38
Sertraline Hcl	Sertraline Hcl	193	28
Simvastatin	Simvastatin	191	47
Tamsulosin Hcl	Tamsulosin Hcl	179	41
Donepezil Hcl	Donepezil Hcl	172	28
Rosuvastatin Calcium	Rosuvastatin Calcium	165	39
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	150	71
Enalapril Maleate	Enalapril Maleate	143	24
Diclofenac Sodium	Diclofenac Sodium	132	30
Nabumetone	Nabumetone	127	47
Furosemide	Furosemide	124	36
Glimepiride	Glimepiride	121	29
Quetiapine Fumarate	Quetiapine Fumarate	120	15
Gemfibrozil	Gemfibrozil	115	35
Glipizide	Glipizide	100	22
Nifedipine Er	Nifedipine	98	25
Finasteride	Finasteride	97	17
Lorazepam	Lorazepam	92	15
Pentoxifylline	Pentoxifylline	89	15
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	85	17
Pioglitazone Hcl	Pioglitazone Hcl	83	24
Acarbose	Acarbose	82	18
Irbesartan	Irbesartan	75	17
Latanoprost	Latanoprost	74	11
Metoprolol Tartrate	Metoprolol Tartrate	73	11
Clopidogrel	Clopidogrel Bisulfate	71	19
Lantus	Insulin Glargine,hum.Rec.Anlog	66	15
Temazepam	Temazepam	66	12
Risperidone	Risperidone	65	11
Xarelto	Rivaroxaban	65	suppressed
Carvedilol	Carvedilol	64	11
Probenecid	Probenecid	63	17
Spironolactone	Spironolactone	63	11
Pravastatin Sodium	Pravastatin Sodium	60	11
Alprazolam	Alprazolam	58	suppressed
Fluticasone Propionate	Fluticasone Propionate	56	34
Levetiracetam	Levetiracetam	55	suppressed
Eliquis	Apixaban	54	suppressed
Trazodone Hcl	Trazodone Hcl	54	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	53	46
Lansoprazole	Lansoprazole	52	suppressed
Terbinafine Hcl	Terbinafine Hcl	51	20
Albuterol Sulfate Hfa	Albuterol Sulfate	50	25
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	48	16
Escitalopram Oxalate	Escitalopram Oxalate	46	suppressed
Folic Acid	Folic Acid	45	suppressed
Atenolol	Atenolol	42	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	40	20
Divalproex Sodium	Divalproex Sodium	40	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	suppressed
Hydralazine Hcl	Hydralazine Hcl	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Propranolol Hcl	Propranolol Hcl	36	suppressed
Humalog	Insulin Lispro	35	suppressed
Prednisone	Prednisone	33	28
Cephalexin	Cephalexin	32	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	13
Doxazosin Mesylate	Doxazosin Mesylate	32	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Allopurinol	Allopurinol	30	12
Buspirone Hcl	Buspirone Hcl	30	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	30	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	28	suppressed
Dexamethasone	Dexamethasone	28	27
Glipizide Er	Glipizide	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	24
Benazepril Hcl	Benazepril Hcl	27	suppressed
Celecoxib	Celecoxib	27	11
Orphenadrine Citrate Er	Orphenadrine Citrate	27	16
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	26	suppressed
Ibuprofen	Ibuprofen	26	14
Hydroxyzine Pamoate	Hydroxyzine Pamoate	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	12
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Digoxin	Digoxin	22	suppressed
Memantine Hcl Er	Memantine Hcl	22	suppressed
Rivastigmine	Rivastigmine	22	suppressed
Baclofen	Baclofen	21	suppressed
Diltiazem Hcl	Diltiazem Hcl	21	suppressed
Glyxambi	Empagliflozin/Linagliptin	21	suppressed
Ibandronate Sodium	Ibandronate Sodium	21	suppressed
Valsartan	Valsartan	21	suppressed
Azithromycin	Azithromycin	20	20
Tradjenta	Linagliptin	20	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Cilostazol	Cilostazol	17	suppressed
Jentadueto	Linagliptin/Metformin Hcl	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Levofloxacin	Levofloxacin	16	16
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Brilinta	Ticagrelor	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Ketoconazole	Ketoconazole	15	12
Meloxicam	Meloxicam	15	suppressed
Naproxen Sodium	Naproxen Sodium	15	11
Olanzapine	Olanzapine	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Ramipril	Ramipril	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Verapamil Sr	Verapamil Hcl	14	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	13	suppressed
Etodolac	Etodolac	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Jentadueto Xr	Linagliptin/Metformin Hcl	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Primidone	Primidone	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Topiramate	Topiramate	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Colchicine	Colchicine	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Potassium Citrate Er	Potassium Citrate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error